​

Bausch + Lomb (BLCO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BLCO Stock Forecast

Bausch + Lomb (BLCO) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $18.00, with a high of $21.00 and a low of $16.00. This represents a 4.17% increase from the last price of $17.28.

$14 $15 $16 $17 $18 $19 $20 $21 High: $21 Avg: $18 Low: $16 Last Closed Price: $17.28

BLCO Stock Rating

Bausch + Lomb stock's rating consensus is Hold, based on 16 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (43.75%), 8 Hold (50.00%), 1 Sell (6.25%), and 0 Strong Sell (0.00%).

Hold
Total 16 0 1 8 7 Strong Sell Sell Hold Buy Strong Buy

BLCO Price Target Upside V Benchmarks

TypeNameUpside
StockBausch + Lomb4.17%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks15.15%

Price Target Trends

1M3M12M
# Anlaysts378
Avg Price Target$20.00$18.00$18.00
Last Closing Price$17.28$17.28$17.28
Upside/Downside15.74%4.17%4.17%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 252310-116
Nov, 253210-116
Oct, 253210-116
Sep, 25428-115
Aug, 25428-115
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2025Morgan Stanley$21.00$16.5626.81%21.53%
Nov 14, 2025Douglas MiehmRBC Capital$19.00$15.6921.10%9.95%
Nov 14, 2025Zachary WeinerJefferies$20.00$15.6927.47%15.74%
Oct 31, 2025H.C. Wainwright$17.00$15.1412.29%-1.62%
Oct 31, 2025Barclays$17.00$15.1412.29%-1.62%
Oct 30, 2025Wells Fargo$16.00$15.473.43%-7.41%
Oct 01, 2025Goldman Sachs$16.00$15.076.17%-7.41%
Mar 27, 2025RBC Capital$18.00$15.0020.00%4.17%
Dec 02, 2024Patrick WoodMorgan Stanley$19.00$19.28-1.45%9.95%
Oct 31, 2024Yi ChenH.C. Wainwright$23.00$20.4412.52%33.10%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2025CitigroupNeutralBuyupgrade
Dec 03, 2025Morgan StanleyOverweightOverweighthold
Dec 02, 2025Morgan StanleyOverweightOverweightupgrade
Nov 14, 2025RBC CapitalOutperformOutperformhold
Nov 14, 2025JefferiesBuyBuyhold
Oct 31, 2025H.C. WainwrightBuyBuyhold
Oct 07, 2025CitigroupNeutralNeutralhold
Oct 01, 2025Goldman SachsNeutralinitialise
Dec 12, 2024JefferiesBuyBuyhold
Oct 31, 2024CitigroupBuyBuyhold

Financial Forecast

EPS Forecast

Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.04$-0.74$-0.90----
Avg Forecast$1.07$0.67$0.58$0.78$1.03$1.23$1.43
High Forecast$1.09$0.72$0.59$0.93$1.17$1.28$1.48
Low Forecast$1.04$0.59$0.57$0.64$0.90$1.20$1.39
Surprise %-96.26%-210.45%-255.17%----

Revenue Forecast

$4B $4B $5B $5B $6B $6B Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.77B$4.15B$4.77B----
Avg Forecast$3.74B$4.08B$4.77B$5.03B$5.33B$5.53B$5.75B
High Forecast$3.80B$4.09B$4.79B$5.15B$5.33B$5.54B$5.90B
Low Forecast$3.67B$3.99B$4.75B$4.92B$5.32B$5.52B$5.63B
Surprise %0.75%1.67%0.11%----

Net Income Forecast

$-350M $-170M $10M $190M $370M $550M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$15.00M$-260.00M$-317.00M----
Avg Forecast$373.56M$228.32M$204.15M$275.08M$362.20M$433.92M$501.22M
High Forecast$381.40M$251.33M$207.56M$325.26M$408.93M$447.13M$518.42M
Low Forecast$364.79M$205.31M$200.75M$224.91M$315.46M$420.71M$487.80M
Surprise %-95.98%-213.88%-255.28%----

BLCO Forecast FAQ

Is Bausch + Lomb stock a buy?

Bausch + Lomb stock has a consensus rating of Hold, based on 16 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 8 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Bausch + Lomb is a neutral investment for most analysts.

What is Bausch + Lomb's price target?

Bausch + Lomb's price target, set by 16 Wall Street analysts, averages $18 over the next 12 months. The price target range spans from $16 at the low end to $21 at the high end, suggesting a potential 4.17% change from the previous closing price of $17.28.

How does Bausch + Lomb stock forecast compare to its benchmarks?

Bausch + Lomb's stock forecast shows a 4.17% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical instruments & supplies stocks industry (15.15%).

What is the breakdown of analyst ratings for Bausch + Lomb over the past three months?

  • December 2025: 12.50% Strong Buy, 18.75% Buy, 62.50% Hold, 0% Sell, 6.25% Strong Sell.
  • November 2025: 18.75% Strong Buy, 12.50% Buy, 62.50% Hold, 0% Sell, 6.25% Strong Sell.
  • October 2025: 18.75% Strong Buy, 12.50% Buy, 62.50% Hold, 0% Sell, 6.25% Strong Sell.

What is Bausch + Lomb’s EPS forecast?

Bausch + Lomb's average annual EPS forecast for its fiscal year ending in December 2025 is $0.78, marking a -186.67% decrease from the reported $-0.9 in 2024. Estimates for the following years are $1.03 in 2026, $1.23 in 2027, and $1.43 in 2028.

What is Bausch + Lomb’s revenue forecast?

Bausch + Lomb's average annual revenue forecast for its fiscal year ending in December 2025 is $5.03B, reflecting a 5.34% increase from the reported $4.77B in 2024. The forecast for 2026 is $5.33B, followed by $5.53B for 2027, and $5.75B for 2028.

What is Bausch + Lomb’s net income forecast?

Bausch + Lomb's net income forecast for the fiscal year ending in December 2025 stands at $275.08M, representing a -186.78% decrease from the reported $-317M in 2024. Projections indicate $362.2M in 2026, $433.92M in 2027, and $501.22M in 2028.